We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Selling over 800 beers across two award-winning brands: We Brought Beer and The Beer Boutique, as well as being one of the UK's largest independent craft beer retailers, Two Heads Beer Co. is seeking investment to further expand the business with 4 new stores already planned in addition to the existing 6 stores with almost £1 million in revenue.

Pitch Rated

64%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £375,040
BioScore is a London-based health technology platform that enables you to easily visualize, track, and understand your fitness and health test results. It is currently designed as a software service for health and fitness professionals, gyms, personal trainers, sports coaches, sports clubs, schools, other allied health consultants and their clients. Leveraging on the trend of health optimization, BioScore aims to provide meaningful infographics and explanations, linked test histories, and personalised advice and action plans from fitness or health experts to their respective end-users, resulting in more effective diagnosis of ailments. The company will utilise the investment to develop an athlete management platform with an inspiring infographic, reporting and sell licences to access the platform's suite of online tools.

Pitch Rated

63%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £57,580
A premium British handcrafted candy-maker seeking funds to expand and grow their business internationally. In addition to their own candy and confectionary, they also offer customers to create their own designs using natural colourings and the finest ingredients. Spun Candy have the rights to the Candy Crush app.

Pitch Rated

62%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £341,990
VPS work with vehicle manufacturers to provide labour such as fitting air conditioning, leather seats, etc. to their cars as they arrive at port from overseas. VPS's main focus is the manufacturing of Number Plates within the Approved British Standard and selling these directly to the car manufacturers.

Pitch Rated

62%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £851,620
EnXray are developing Low Energy X-ray (LEXR) technologies to sterilise equipment in commercial or research settings where low volume/high value therapeutic products, such as cancer vaccines and stem cell implants are being developed. Their aim is to reduce the need for third party providers and have the sterilisation process done on-site and on-demand with simple and safe equipment to reduce cost and save time for medical research organisations.

Pitch Rated

61%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £376,230
som saa is a unique cocktail bar and restaurant located in Spitalfields, London. It serves high quality regional Thai cuisines made with uncompromising flavours. som saa has more than 27,000 followers on Instagram and carries a loyal customer following. In 2016, som saa became the Restaurant of the Year sponsored by The London Restaurant Festival. It is planning to open a second restaurant in Central London. Approximately 32.5% of the proceeds will be used for building and direct works; 20% will be used for kitchen design, building, and extraction; 14% will be used for professional fees; 5% for bar installation; and 28.5% other opening costs.

Pitch Rated

61%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £253,633
Big Night is an online food delivery service that partners with selected independent food vendors to deliver exceptional meals to customers at home, in their office or wherever they choose. The company asserts that 61% of non-millennials find delivery overall frustrating. Big Night aims to change this scenario. It has signed on ten notable restaurants and has ten more in the immediate pipeline. Onboarded restaurants include Two Lights, Luca, The Laughing Heart, Sager + Wilde, Royale, Levan, AngloThai, Legare and Mangal2. Over 4,000 people have ordered via Big Night since its launch. The company will use 25% of the investment for operations, 25% for marketing, and 50% to improve the Big Night platform.

Pitch Rated

60%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £274,168
Market Halls (MH) takes unloved public spaces and transforms them into destinations for all-day drinking and dining. MH claims to offer something for everyone, taking visitors seamlessly from breakfast through to late-night snacks. It argues that it has established three venues in Fulham, Victoria and the West End that have attracted crowds in excess of 1.04 million in 2019. MH asserts that it received a Net Promoter Score (NPS) of 62, generated £15 million in revenue in 2020, and has featured in publications such as The Telegraph, The Guardian and Independent. MH also stresses that it has a ‘Best in Class’ retention rate of 80% repeat business. It states it will use the investment to scale up its business with a new identity, new gold-dust venues and an improved customer offering.

Pitch Rated

60%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £787,240
By combining fitness with fashion, art and design, BLOK has become a major competitor of boutique class-based gyms within London. BLOK has appeared on Britain's Next Top Model, as well as working with global stars including Anthony Joshua and Jordan Dunn.

Pitch Rated

60%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £891,790
TC BioPharm is an immunotherapy company. It has used its patented technology to harness the power of a particular part of the immune system, Gamma Delta T-cells (GDT), to negate cancer cells in the human body. TC BioPharm has treated terminally ill patients with acute myeloid leukaemia in approved clinical trials garnering positive responses from multiple patients. The company has received regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to run a COVID-19 clinical trial to address the global pandemic. TC BioPharm aims to use its current technology to provide a frozen product that can be manufactured cost-effectively and distributed globally. The company has already raised over £7 million in the last 15 months. It will use the investment to take its clinical trials forward in COVID-19 and cancer.

Pitch Rated

59%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,753,067
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph